10222-61-4 Usage
Uses
Since Dibucaine Impurity D is an impurity, it does not have direct applications in the same way as the main active ingredient, dibucaine. However, its identification and control are essential in the following areas:
Used in Pharmaceutical Quality Control:
Dibucaine Impurity D is monitored and controlled as a part of the quality assurance process for dibucaine products. It is used as an indicator of purity for ensuring that the medication meets regulatory requirements for safety and efficacy.
Used in Regulatory Compliance:
Dibucaine Impurity D is used as a benchmark in regulatory compliance checks to verify that dibucaine products adhere to the established standards for purity. This helps in maintaining the integrity and reliability of the pharmaceutical products in the market.
Check Digit Verification of cas no
The CAS Registry Mumber 10222-61-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,2 and 2 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10222-61:
(7*1)+(6*0)+(5*2)+(4*2)+(3*2)+(2*6)+(1*1)=44
44 % 10 = 4
So 10222-61-4 is a valid CAS Registry Number.
10222-61-4Relevant articles and documents
QUINOLINE DERIVATIVE HAVING SEROTONIN-3 RECEPTOR ANTAGONIZING ACTIVITY
-
, (2008/06/13)
Quinoline derivatives represented by formula (I): STR1 wherein A-B-D represents--C(COO--Y)=CH--C(OR)= (wherein Y represents 8-methyl-8-azabicyclo[3.2.1]oct-3-yl group and R represents alkyl) or--C(OH)=C(COX--Y)--CH= (wherein X represents--O--or--NH--; and Y has the same meaning as described above), or a pharmaceutically acceptable salt thereof, possess potent 5HT 3 antagonizing activity and are useful as antiemetic agents.
5-HT3 Receptor Antagonists. 1. New Quinoline Derivatives
Hayashi, Hiroaki,Miwa, Yoshikazu,Miki, Ichiro,Ichikawa, Shunji,Yoda, Noboyuki,et al.
, p. 4893 - 4902 (2007/10/02)
A series of esters and amides of 1-alkyl-2-oxo-1,2-dihydroquinoline-4-carboxylic acid or 2-alkoxyquinoline-4-carboxylic acid containing a basic azabicycloalkyl moiety has been synthesized and evaluated for affinity for the 3H>quipazine-labeled
